{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:11:06Z","timestamp":1772003466255,"version":"3.50.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30HD113414"],"award-info":[{"award-number":["F30HD113414"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM008042"],"award-info":[{"award-number":["T32GM008042"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM152342"],"award-info":[{"award-number":["T32GM152342"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30HD113414"],"award-info":[{"award-number":["F30HD113414"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM008042"],"award-info":[{"award-number":["T32GM008042"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM152342"],"award-info":[{"award-number":["T32GM152342"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Praemium Academiae of the Czech Academy of Sciences"},{"name":"Joshua S. and Beth C. Friedman Chair in Women\u2019s Genetic Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Osteogenesis imperfecta, a genetically heterogeneous disorder, is characterized by brittle bones with recurrent fractures as well as short stature. A recent study investigating cellular signaling in growth plate chondrocytes identified an increased expression of FGF receptors and elevated FGF signaling. We inhibited FGF receptor activation with the small molecule infigratinib in growing Aga2\/+ mice and then characterized linear growth, cartilage growth plate histology, and bone morphometrics. Infigratinib treatment resulted in increased female femur length, increased growth plate lengths in both sexes, specifically in the proliferative zone, and reduced phospho-ERK1\/2 as well as SOX9 expression in lower hypertrophic chondrocytes. Infigratinib had no impact on cortical bone but reduced male trabecular bone parameters in Aga2\/+ mice. Three point bending biomechanical tests showed that Aga2\/+-treated males had increased bone strength for some parameters, but reduced bone strength in treated WT males, correlating with the negative impact on trabecular bone parameters. WT and Aga2-treated male mice also showed increased serum testosterone levels. Together, these data establish FGFR as a therapeutic target for short stature in osteogenesis imperfecta and identify potential negative effects of pan-FGFR inhibition, particularly in the male skeleton.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziag005","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:26:49Z","timestamp":1768307209000},"source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of FGFR signaling with infigratinib improves linear bone growth in the female\n                    <i>Aga2\/+<\/i>\n                    mouse model of osteogenesis imperfecta"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2355-0630","authenticated-orcid":false,"given":"Alexander","family":"Kot","sequence":"first","affiliation":[{"name":"Orthopaedic Surgery, David Geffen School of Medicine at University of California at Los Angeles , Los Angeles, CA 90095 ,","place":["United States"]},{"name":"Human Genetics, David Geffen School of Medicine at University of California at Los Angeles , Los Angeles, CA 90095 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Wight","sequence":"additional","affiliation":[{"name":"Orthopaedic Surgery, David Geffen School of Medicine at University of California at Los Angeles , Los Angeles, CA 90095 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roya","family":"Bagheri","sequence":"additional","affiliation":[{"name":"Orthopaedic Surgery, David Geffen School of Medicine at University of California at Los Angeles , Los Angeles, CA 90095 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8369-3919","authenticated-orcid":false,"given":"Davis","family":"Wachtell","sequence":"additional","affiliation":[{"name":"Orthopaedic Surgery, David Geffen School of Medicine at University of California at Los Angeles , Los Angeles, CA 90095 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma","family":"Rios","sequence":"additional","affiliation":[{"name":"Orthopaedic Surgery, David Geffen School of Medicine at University of California at Los Angeles , Los Angeles, CA 90095 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Bober","sequence":"additional","affiliation":[{"name":"Orthopaedic Surgery, David Geffen School of Medicine at University of California at Los Angeles , Los Angeles, CA 90095 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cora","family":"Chun","sequence":"additional","affiliation":[{"name":"Orthopaedic Surgery, David Geffen School of Medicine at University of California at Los Angeles , Los Angeles, CA 90095 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0618-9134","authenticated-orcid":false,"given":"Pavel","family":"Krejci","sequence":"additional","affiliation":[{"name":"Department of Biology, Faculty of Medicine, Masaryk University , Brno, 625 00 ,","place":["Czech Republic"]},{"name":"International Clinical Research Center, St. Anne\u2019s University Hospital , Brno, 656 91 ,","place":["Czech Republic"]},{"name":"Institute of Animal Physiology and Genetics, Czech Academy of Sciences , Brno, 602 00 ,","place":["Czech Republic"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1650-1830","authenticated-orcid":false,"given":"Jennifer","family":"Zieba","sequence":"additional","affiliation":[{"name":"Orthopaedic Surgery, David Geffen School of Medicine at University of California at Los Angeles , Los Angeles, CA 90095 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Krakow","sequence":"additional","affiliation":[{"name":"Orthopaedic Surgery, David Geffen School of Medicine at University of California at Los Angeles , Los Angeles, CA 90095 ,","place":["United States"]},{"name":"Human Genetics, David Geffen School of Medicine at University of California at Los Angeles , Los Angeles, CA 90095 ,","place":["United States"]},{"name":"Obstetrics and Gynecology, David Geffen School of Medicine at University of California at Los Angeles , Los Angeles, CA 90095 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"9418","key":"2026022501312660300_ref1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"2026022501312660300_ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.52","article-title":"Osteogenesis imperfecta","volume":"3","author":"Marini","year":"2017","journal-title":"Nat Rev Dis Primer"},{"issue":"2","key":"2026022501312660300_ref3","first-page":"275","article-title":"Growth characteristics in individuals with osteogenesis imperfecta in North America: results from a multicenter study","volume":"21","author":"Jain","year":"2019","journal-title":"Genet Med Off J Am Coll Med Genet"},{"issue":"3","key":"2026022501312660300_ref4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/pr.2015.230","article-title":"Cross-sectional and longitudinal growth patterns in osteogenesis imperfecta: implications for clinical care","volume":"79","author":"Germain-Lee","year":"2016","journal-title":"Pediatr Res"},{"issue":"1","key":"2026022501312660300_ref5","doi-asserted-by":"publisher","first-page":"101168","DOI":"10.1016\/j.dhjo.2021.101168","article-title":"Living with osteogenesis imperfecta: a qualitative study exploring experiences and psychosocial impact from the perspective of patients, parents and professionals","volume":"15","author":"Hill","year":"2022","journal-title":"Disabil Health J"},{"issue":"8","key":"2026022501312660300_ref6","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s11136-016-1247-0","article-title":"The psychosocial experience of individuals living with osteogenesis imperfecta: a mixed-methods systematic review","volume":"25","author":"Tsimicalis","year":"2016","journal-title":"Qual Life Res"},{"issue":"21","key":"2026022501312660300_ref7","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.171984","article-title":"Altered Sox9 and FGF signaling gene expression in Aga2 OI mice negatively affects linear growth","volume":"8","author":"Zieba","year":"2023","journal-title":"JCI Insight"},{"issue":"1","key":"2026022501312660300_ref8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbrc.2018.12.111","article-title":"Endoplasmic reticulum stress is induced in growth plate hypertrophic chondrocytes in G610C mouse model of osteogenesis imperfecta","volume":"509","author":"Scheiber","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"2026022501312660300_ref9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bbrc.2022.04.138","article-title":"Impaired proliferation of growth plate chondrocytes in a model of osteogenesis imperfecta","volume":"613","author":"Lv","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"2026022501312660300_ref10","doi-asserted-by":"publisher","first-page":"e1004820","DOI":"10.1371\/journal.pgen.1004820","article-title":"Chondrocytes transdifferentiate into osteoblasts in endochondral bone during development, postnatal growth and fracture healing in mice","volume":"10","author":"Zhou","year":"2014","journal-title":"PLoS Genet"},{"issue":"3","key":"2026022501312660300_ref11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/dvdy.278","article-title":"Making and shaping endochondral and intramembranous bones","volume":"250","author":"Galea","year":"2021","journal-title":"Dev Dyn"},{"issue":"2","key":"2026022501312660300_ref12","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1371\/journal.pgen.0040007","article-title":"ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta","volume":"4","author":"Lisse","year":"2008","journal-title":"PLoS Genet"},{"issue":"1","key":"2026022501312660300_ref13","first-page":"1","article-title":"Role of FGF\/FGFR signaling in skeletal development and homeostasis: learning from mouse models","volume":"2","author":"Su","year":"2014","journal-title":"Bone Res Nature Publishing Group"},{"issue":"3","key":"2026022501312660300_ref14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1073\/pnas.97.3.1113","article-title":"Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway","volume":"97","author":"Murakami","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2026022501312660300_ref15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/427956","article-title":"Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation","volume":"76","author":"White","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2026022501312660300_ref16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S2352-4642(23)00265-1","article-title":"Vosoritide therapy in children with achondroplasia aged 3\u221259 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"8","author":"Savarirayan","year":"2024","journal-title":"Lancet Child Adolesc"},{"issue":"20","key":"2026022501312660300_ref17","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1021\/jm2006222","article-title":"Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase","volume":"54","author":"Guagnano","year":"2011","journal-title":"J Med Chem"},{"issue":"12","key":"2026022501312660300_ref18","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1158\/2159-8290.CD-12-0210","article-title":"FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor","volume":"2","author":"Guagnano","year":"2012","journal-title":"Cancer Discov"},{"issue":"5","key":"2026022501312660300_ref19","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1172\/JCI83926","article-title":"Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model","volume":"126","author":"Komla-Ebri","year":"2016","journal-title":"J Clin Invest"},{"issue":"6","key":"2026022501312660300_ref20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/jbmr\/zjae051","article-title":"Low\u2013dose infigratinib increases bone growth and corrects growth plate abnormalities in an achondroplasia mouse model","volume":"39","author":"Demuynck","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2026022501312660300_ref21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMoa2411790","article-title":"Oral Infigratinib therapy in children with achondroplasia","volume":"392","author":"Savarirayan","journal-title":"N Engl J Med"},{"issue":"6","key":"2026022501312660300_ref22","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/jbmr.2539","article-title":"Establishing biomechanical mechanisms in mouse models: practical guidelines for systematically evaluating phenotypic changes in the diaphyses of long bones","volume":"30","author":"Jepsen","year":"2015","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"2","key":"2026022501312660300_ref23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0012-1606(03)00321-X","article-title":"MAP kinases in chondrocyte differentiation","volume":"263","author":"Stanton","year":"2003","journal-title":"Dev Biol"},{"issue":"9","key":"2026022501312660300_ref24","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1093\/hmg\/ddv019","article-title":"FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation","volume":"24","author":"Karolak","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2026022501312660300_ref25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gad.1179104","article-title":"Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype","volume":"18","author":"Murakami","year":"2004","journal-title":"Genes Dev"},{"issue":"3","key":"2026022501312660300_ref26","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.devcel.2011.12.024","article-title":"Sox9 directs hypertrophic maturation and blocks osteoblast differentiation of growth plate chondrocytes","volume":"22","author":"Dy","year":"2012","journal-title":"Dev Cell"},{"issue":"9","key":"2026022501312660300_ref27","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1124\/dmd.121.000508","article-title":"Infigratinib is a reversible inhibitor and mechanism-based inactivator of cytochrome P450 3A4","volume":"49","author":"Tang","year":"2021","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"issue":"4","key":"2026022501312660300_ref28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/138920008784220664","article-title":"Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4","volume":"9","author":"Zhou","year":"2008","journal-title":"Curr Drug Metab"},{"key":"2026022501312660300_ref29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jsbmb.2016.04.018","article-title":"Cyp3a deficiency enhances androgen receptor activity and cholesterol synthesis in the mouse prostate","volume":"163","author":"Hashimoto","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"2026022501312660300_ref30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.canlet.2004.10.007","article-title":"Cytochrome P450-mediated metabolism of estrogens and its regulation in human","volume":"227","author":"Tsuchiya","year":"2005","journal-title":"Cancer Lett"},{"issue":"42","key":"2026022501312660300_ref31","doi-asserted-by":"crossref","first-page":"16558","DOI":"10.1073\/pnas.0702581104","article-title":"Fibroblast growth factor receptor 2 regulates proliferation and sertoli differentiation during male sex determination","volume":"104","author":"Kim","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"2026022501312660300_ref32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fendo.2019.00118","article-title":"Fibroblast growth factor 1 promotes rat stem Leydig cell development","volume":"10","author":"Chen","year":"2019","journal-title":"Front Endocrinol"},{"issue":"11","key":"2026022501312660300_ref33","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1093\/humrep\/dez191","article-title":"Dysregulation of FGFR signalling by a selective inhibitor reduces germ cell survival in human fetal gonads of both sexes and alters the somatic niche in fetal testes","volume":"34","author":"Harpelunde Poulsen","year":"2019","journal-title":"Hum Reprod"},{"issue":"1","key":"2026022501312660300_ref34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08977190903299379","article-title":"Inhibition of LH-stimulated androgen production in rat immature Leydig cells: effects on nuclear receptor steroidogenic factor 1 by FGF2","volume":"28","author":"Xiao","year":"2010","journal-title":"Growth Factors Chur Switz"},{"key":"2026022501312660300_ref35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bone.2019.05.027","article-title":"Persistent Sox9 expression in hypertrophic chondrocytes suppresses transdifferentiation into osteoblasts","volume":"125","author":"Lui","year":"2019","journal-title":"Bone."},{"issue":"2","key":"2026022501312660300_ref36","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.joca.2016.10.007","article-title":"SOX9 protein is stabilized by TGF-\u03b2 and regulates PAPSS2 mRNA expression in chondrocytes","volume":"25","author":"Chavez","year":"2017","journal-title":"Osteoarthr Cartil"},{"issue":"4","key":"2026022501312660300_ref37","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/term.1744","article-title":"FGF, TGF\u03b2 and Wnt crosstalk: embryonic to in vitro cartilage development from mesenchymal stem cells","volume":"9","author":"Cleary","year":"2015","journal-title":"J Tissue Eng Regen Med"},{"issue":"14","key":"2026022501312660300_ref38","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1101\/gad.266551.115","article-title":"Fibroblast growth factor signaling in skeletal development and disease","volume":"29","author":"Ornitz","year":"2015","journal-title":"Genes Dev"},{"issue":"1","key":"2026022501312660300_ref39","first-page":"1","article-title":"FGF\/FGFR signaling in health and disease","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2026022501312660300_ref40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/hmg\/ddh034","article-title":"Defective bone mineralization and osteopenia in young adult FGFR3\u2212\/\u2212 mice","volume":"13","author":"Valverde-Franco","year":"2004","journal-title":"Hum Mol Genet"},{"issue":"13","key":"2026022501312660300_ref41","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1242\/dev.00491","article-title":"Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth","volume":"130","author":"Yu","year":"2003","journal-title":"Development."},{"issue":"12","key":"2026022501312660300_ref42","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/dvdy.642","article-title":"Infigratinib, a selective FGFR1-3 tyrosine kinase inhibitor, alters dentoalveolar development at high doses","volume":"252","author":"Michel","year":"2023","journal-title":"Dev Dyn"},{"issue":"26","key":"2026022501312660300_ref43","doi-asserted-by":"crossref","first-page":"11853","DOI":"10.1073\/pnas.1003317107","article-title":"Fgf-9 is required for angiogenesis and osteogenesis in long bone repair","volume":"107","author":"Behr","year":"2010","journal-title":"Proc Natl Acad Sci"},{"issue":"15\u201316","key":"2026022501312660300_ref44","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1089\/ten.TEA.2010.0719","article-title":"Fgf-18 is required for osteogenesis but not angiogenesis during long bone repair","volume":"17","author":"Behr","year":"2011","journal-title":"Tissue Eng"},{"issue":"10","key":"2026022501312660300_ref45","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/sctm.17-0039","article-title":"Acceleration of fracture healing by overexpression of basic fibroblast growth factor in the mesenchymal stromal cells","volume":"6","author":"Zhang","year":"2017","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"2026022501312660300_ref46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s41232-019-0109-x","article-title":"Clinical application of injectable growth factor for bone regeneration: a systematic review","volume":"39","author":"Kuroda","year":"2019","journal-title":"Inflamm Regen"},{"key":"2026022501312660300_ref47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s41232-017-0043-8","article-title":"Role of fibroblast growth factors in bone regeneration","volume":"37","author":"Charoenlarp","year":"2017","journal-title":"Inflamm Regen"},{"issue":"22","key":"2026022501312660300_ref48","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1242\/dev.152587","article-title":"Fibroblast growth factors: key players in regeneration and tissue repair","volume":"144","author":"Maddaluno","year":"2017","journal-title":"Development."},{"issue":"1","key":"2026022501312660300_ref49","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1186\/s12891-022-05966-7","article-title":"Incidence and nonunion rates of tibial fractures in adults with osteogenesis imperfecta: a retrospective cohort study of 402 patients with 42 fractures at an expert clinic","volume":"23","author":"Munk","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"key":"2026022501312660300_ref50","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2147\/CIA.S115472","article-title":"A concise review of testosterone and bone health","volume":"11","author":"Mohamad","year":"2016","journal-title":"Clin Interv Aging"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziag005\/66405024\/ziag005.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/10\/3\/ziag005\/66405024\/ziag005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/10\/3\/ziag005\/66405024\/ziag005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:31:38Z","timestamp":1772001098000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziag005\/8424998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziag005","relation":{},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,1,14]]},"article-number":"ziag005"}}